Sands Capital Ventures Discovery Fund III, L.P.

ABOS

Sands Capital Ventures Discovery Fund III, L.P. serves as 10% Owner at Acumen Pharmaceuticals, Inc. (ABOS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$6.70M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$6.70M

Companies Traded

ABOS

Active Period

Jul 2021

1 total trades

Most Recent

Buy ABOS

Jul 8, 2021 · $6.70M

Sands Capital Ventures Discovery Fund III, L.P.'s Insider Trading at Acumen Pharmaceuticals, Inc. (ABOS)

Buys

1 · $6.70M

Sells

0 · $0.00

Total Shares Bought

450,000

Total Shares Sold

ABOS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 8, 2021	Buy	450,000	$14.88	$6.70M	3,417,075

Related Insiders

Nathan B Fountain

director

ABOSSell · Jun 10, 2026

Derek M Meisner

officer: Chief Legal Officer & Corp Sec

ABOSSell · Mar 10, 2026

Matt Zuga

officer: CFO & Chief Business Officer

ABOSSell · Jan 23, 2026

Eric Siemers

officer: Chief Medical Officer

ABOSSell · Jan 23, 2026

Russell Barton

officer: Chief Operating Officer

ABOSSell · Jan 23, 2026

Daniel Joseph OConnell

director, officer: Chief Executive Officer

ABOSSell · Jan 23, 2026

James J. Doherty

President and CDO

ABOSSell · Jan 9, 2026

Amy Schacterle

officer: Chief Regulatory Officer

ABOSSell · Jan 9, 2026

Explore More Insider Trading Data

ABOS Insider Trading Activity

View all insider trades at Acumen Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity